CALL 800-775-7784 | 516-300-1281

ABOUT US
| RESEARCH | NEWS | EVENTS | CONTACT
treatments / services
research  


CLINICAL STUDIES - JUNE 2008

clinical trialsDr Jai Grewal and Dr Paul Duic will be conducting clinical studies

Study Criteria:  Patients must have confirmed non-small cell lung cancer and 1-3 brain metastases.  

Title:  A Phase III Trial Comparing Whole Brain Radiation and Stereotactic Radiosurgery Alone versus Temozolomide or Erlotinib in Patients with Non-Small Cell Lung Cancer and 1-3 Brain Metastases 

Protocol:  RTOG 0320

SNCH Co-Investigators:  Jai Grewal, M.D., and J. Paul Duic, M.D.

Sponsor:  Radiation Therapy Oncology Group

Objective:  To determine if either erlotinib or temozolomide combined with radiation therapy, as compared with radiation alone, improves survival for persons with non-small cell lung cancer and brain metastases.     

 

For more information or to see if one qualifies for this study, call 516-478-0010 or 631-864-3900. 

 


 

 

 

 

 

 

 

All Rights Reserved 2005-9 | Neurological Surgery, P.C. | info@neurosurgeryli.com

 

divider

 

site by islandguide.com